XML 21 R9.htm IDEA: XBRL DOCUMENT v3.3.1.900
EQUITY-BASED COMPENSATION PLANS
6 Months Ended
Dec. 27, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
EQUITY-BASED COMPENSATION PLANS
EQUITY-BASED COMPENSATION PLANS
The Company has stock plans that provide for grants of equity-based awards to eligible participants, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“market-based PRSUs”) of Lam Research common stock (“Common Stock”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s market-based PRSUs contain both a market condition and a service condition. The Company’s options and RSU awards typically vest over a period of three years or less. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions.

The Company recognized the following equity-based compensation expense and related income tax benefit in the Condensed Consolidated Statements of Operations:
 
Three Months Ended
 
Six Months Ended
 
December 27,
2015
 
December 28,
2014
 
December 27,
2015
 
December 28,
2014
 
(in thousands)
Equity-based compensation expense
$
32,570

 
$
30,632

 
$
68,344

 
$
62,672

Income tax benefit related to equity-based compensation expense
$
12,651

 
$
6,116

 
$
18,748

 
$
10,840


The estimated fair value of the Company’s stock-based awards, less expected forfeitures, is amortized over the awards’ vesting term on a straight-line basis.
Stock Options and RSUs
The Lam Research Corporation 2015 Stock Incentive Plan, 2007 Stock Incentive Plan, as amended and 2011 Stock Incentive Plan, as amended (collectively the “Stock Plans”) provide for the grant of non-qualified equity-based awards to eligible employees, consultants and advisors, and non-employee directors of the Company and its subsidiaries. A summary of stock plan transactions is as follows:
 
Options Outstanding
 
Restricted Stock Units Outstanding
 
Number of
Shares
 
Weighted-
Average
Exercise Price
 
Number of
Shares
 
Weighted-
Average
Fair Market
Value
at Grant
June 28, 2015
835,832

 
$
37.44

 
4,954,088

 
$
60.13

Granted

 
$

 
151,462

 
$
71.46

Exercised
(70,291
)
 
$
22.03

 
N/A

 
N/A

Canceled

 
$

 
(46,193
)
 
$
65.08

Vested restricted stock
N/A

 
N/A

 
(1,247,240
)
 
$
46.19

December 27, 2015
765,541

 
$
38.86

 
3,812,117

 
$
65.08


As of December 27, 2015, there was $2.0 million of total unrecognized compensation cost related to unvested stock options granted and outstanding; that cost is expected to be recognized over a weighted-average remaining vesting period of 1.8 years. As of December 27, 2015, there was $146.5 million of total unrecognized compensation expense related to unvested RSUs granted; that expense is expected to be recognized over a weighted-average remaining period of 1.8 years.
ESPP
The 1999 Employee Stock Purchase Plan, as amended and restated (the “1999 ESPP”), allows employees to designate a portion of their base compensation to be withheld through payroll deductions and used to purchase Common Stock at a purchase price per share equal to the lower of 85% of the fair market value of Common Stock on the first or last day of the applicable purchase period. Each offering period generally lasts up to 12 months and includes up to three interim purchase dates.
Purchase rights under the 1999 ESPP were valued using the Black-Scholes option valuation model and the following weighted-average assumptions for the six months ended December 27, 2015 and December 28, 2014: 
 
Six Months Ended
December 27,
2015
 
December 28,
2014
Expected term (years)
0.67

 
0.68

Expected stock price volatility
31.86
%
 
29.07
%
Risk-free interest rate
0.19
%
 
0.07
%
Dividend Yield
0.94
%
 
0.29
%

There were no ESPP purchases during the quarter ended December 27, 2015. As of December 27, 2015, there was $11.7 million of unrecognized compensation expense related to the 1999 ESPP, which is expected to be recognized over a remaining period of approximately eight months.